CDD-1845
CDD-1845 is a non-covalent and non-peptide potent SARS-CoV-2 Mpro inhibitor with a Ki of 3 nM. CDD-1845 also inhibits ΔP168, A173V, and ΔP168/A173V Mpro variants[1].
Product Specifications
CAS Number
2894104-50-6
UNSPSC
12352005
Target
SARS-CoV
Type
Reference compound
Related Pathways
Anti-infection
Applications
COVID-19-anti-virus
Field of Research
Infection
Assay Protocol
https://www.medchemexpress.com/cdd-1845.html
Purity
99.60
Solubility
DMSO : ≥ 100 mg/mL
Smiles
O=C(NC)CCCN1C(C2=C(C=CC=C3)C3=CN=C2)=NC4=C1C(C(N[C@@H](C)C5=CC=C(C=CC=C6)C6=C5)=O)=CC=C4
Molecular Formula
C34H31N5O2
Molecular Weight
541.64
References & Citations
[1]Ravikumar Jimmidi, et al. DNA-encoded chemical libraries yield non-covalent and non-peptidic SARS-CoV-2 main protease inhibitors. Commun Chem. 2023 Aug 4;6 (1) :164.
Shipping Conditions
Room Temperature
Storage Conditions
4°C (Powder, stored under nitrogen)
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
197037 1 Pack (1 Panel (s) x 1 Pack)
P/P042/FR613/PP-297X105-1 Prohibited Activity Signs (No Adhesive)
Sign In for Pricing
View Details 
19239111 3x 1.0 µg
ELOVL7 sgRNA CRISPR/Cas9 All-in-One Lentivector set (Human)
Sign In for Pricing
View Details 
orb2619530 100 µg
Cytochrome P450 Reductase/POR Rabbit Polyclonal Antibody (Biotin)
Sign In for Pricing
View Details 